ENA Respiratory is a clinical-stage pharmaceutical company developing INNA-051, an intranasal innate immune modulator for the prevention of complications resulting from respiratory viral infections in at-risk populations, including older adults, those with co-morbidities (COPD, asthma, diabetes, and...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (6 years)
Address:
31 QUEEN STREET; MELBOURNE, VICTORIA 3000, AU
LOW
spending power
